Provided by Tiger Trade Technology Pte. Ltd.

Vivos Therapeutics

0.1767
-0.0073-3.97%
Post-market: 0.1740-0.0027-1.53%19:56 EDT
Volume:1.14M
Turnover:199.91K
Market Cap:3.55M
PE:-0.10
High:0.1809
Open:0.1790
Low:0.1720
Close:0.1840
52wk High:3.70
52wk Low:0.1575
Shares:20.12M
Float Shares:19.87M
Volume Ratio:0.09
T/O Rate:5.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8267
EPS(LYR):-2.0700
ROE:-8585.26%
ROA:-56.19%
PB:-0.72
PE(LYR):-0.09

Loading ...

May 16, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 17, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2025

Major Issues Report

Form 8-K - Current report
Jan 29, 2025

Correspondence

Form CORRESP - Correspondence
Jan 29, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 22, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 23, 2024

Major Issues Report

Form 8-K - Current report
Nov 27, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 15, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 24, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 20, 2024

Major Issues Report

Form 8-K - Current report
Sep 18, 2024

Major Issues Report

Form 8-K - Current report
Sep 18, 2024

Major Issues Report

Form 8-K - Current report
Sep 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Major Issues Report

Form 8-K - Current report